The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -10.01 — distress zone — historically elevated failure riskWatch
Leadership changes
From Quoin Pharmaceuticals, Ltd.'s own filings, the day they're filed.
- Sally Lawlor · Chief Financial Officer · appointmenteff. 2025-08-18
- Gordon Dunn · Chief Financial Officer · departureeff. 2025-08-15
- Mutual Separation · Chief Financial Officer · departureeff. 2025-07-03
Latest filings
- 8-K · Company announcement2026-06-04
- 10-Q · Quarterly report2026-05-07
- 8-K · Company announcement2026-05-07
- 8-K · Company announcement2026-03-26
- 10-K · Annual report2026-03-26
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about Quoin Pharmaceuticals, Ltd., every answer cited🔒
- The Intelligence Brief — added when Quoin Pharmaceuticals, Ltd.'s brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.